Medical Devices industry cross border deals total $3.1bn globally in June 2022

Total Medical devices industry cross border deals worth $3.1bn were announced globally for June 2022, with the $1bn acquisition of MediFox DAN Group being the sector’s biggest investment, according to GlobalData’s deals database.

The value marked an increase of 305.4% over the previous month of $774.46m and a drop of 15.8% when compared with the last 12-month average of $3.73bn.

In terms of number of cross border deals, the sector saw a rise of 1.69% with 60 deals in June 2022 when compared to the last 12-month average of 59 deals.

In value terms, Europe led the activity with cross border deals worth $2.13bn in June 2022.

Medical devices industry cross border deals in June 2022: Top deals

The top five cross border deals accounted for 73.7% of the overall value during June 2022.

The combined value of the top five cross border deals stood at $2.32bn, against the overall value of $3.1bn recorded for the month.

The top five Medical devices industry cross border deals of June 2022 tracked by GlobalData were:

1) ResMed $1bn acquisition deal with MediFox DAN Group

2) The $797.86m private equity of SPT Labtech by EQT IX Fund

3) Boston Scientific $230m acquisition deal for 64% stake in M.I.Tech

4) The $177.8m acquisition of Guardant Health AMEA by Guardant Health

5) Alpha Intelligence Capital,CDIB Capital and TCMI $110m venture financing deal with Aidoc Medical